VFA
OSIR

Virtus Fund Advisers’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Virtus Fund Advisers’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,618
Closed -$25K – 2785
2014
Q2 		$25K Buy
+1,618
New +$23.8K ﹤0.01% 2323

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtus Fund Advisers's OSIR Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2014, closing a stake of 1,618 shares — an estimated $25K sold.

Virtus Fund Advisers first reported a position in OSIR in Q2 2014 and held it in 1 quarter. The position peaked at $25K in Q2 2014. 67 funds tracked by Wall St. Rank hold OSIR as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,618 Osiris Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $25K.
  • Virtus Fund Advisers first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Osiris Therapeutics, Inc. Common Stock position peaked at $25K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.